Riluzole in Spinal Cord Injury Study (RISCIS)-Pharmacokinetic (PK) Sub-Study: An Analysis of Pharmacokinetics, Pharmacodynamics, and Impact on Axonal Degradation of Riluzole in Patients With Traumatic Cervical Spinal Cord Injury Enrolled in the RISCIS Phase III Randomized Controlled Trial.
Saved in:
| Title: | Riluzole in Spinal Cord Injury Study (RISCIS)-Pharmacokinetic (PK) Sub-Study: An Analysis of Pharmacokinetics, Pharmacodynamics, and Impact on Axonal Degradation of Riluzole in Patients With Traumatic Cervical Spinal Cord Injury Enrolled in the RISCIS Phase III Randomized Controlled Trial. |
|---|---|
| Authors: | Chow DS; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas, USA., Nguyen A; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas, USA.; Janssen Pharmaceutical Companies of Johnson & Johnson, Philadelphia, Pennsylvania, USA., Park J; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas, USA., Wu L; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas, USA.; AbbVie Pharmaceuticals, Chicago, Illinois, USA., Toups EG; Department of Neurosurgery, Houston Methodist Research Institute, Houston, Texas, USA., Harrop JS; Department of Neurosurgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Guest JD; Department of Neurological Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA., Schmitt KM; Department of Neurosurgery, Health Science Center, University of Texas, Houston, Texas, USA., Aarabi B; Department of Neurosurgery, University of Maryland, Baltimore, Maryland, USA., Fehlings MG; Division of Neurosurgery and Spine Program, Toronto Western Hospital, University of Toronto, Ontario, Canada., Boakye M; Department of Neurosurgery, University of Louisville, Louisville, Kentucky, USA., Grossman RG; Department of Neurosurgery, Houston Methodist Research Institute, Houston, Texas, USA. |
| Source: | Journal of neurotrauma [J Neurotrauma] 2023 Sep; Vol. 40 (17-18), pp. 1889-1906. |
| Publication Type: | Randomized Controlled Trial; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 8811626 Publication Model: Print Cited Medium: Internet ISSN: 1557-9042 (Electronic) Linking ISSN: 08977151 NLM ISO Abbreviation: J Neurotrauma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37130044 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Riluzole in Spinal Cord Injury Study (RISCIS)-Pharmacokinetic (PK) Sub-Study: An Analysis of Pharmacokinetics, Pharmacodynamics, and Impact on Axonal Degradation of Riluzole in Patients With Traumatic Cervical Spinal Cord Injury Enrolled in the RISCIS Phase III Randomized Controlled Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chow+DS%22">Chow DS</searchLink>; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Nguyen+A%22">Nguyen A</searchLink>; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas, USA.; Janssen Pharmaceutical Companies of Johnson & Johnson, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Park+J%22">Park J</searchLink>; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Wu+L%22">Wu L</searchLink>; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas, USA.; AbbVie Pharmaceuticals, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Toups+EG%22">Toups EG</searchLink>; Department of Neurosurgery, Houston Methodist Research Institute, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Harrop+JS%22">Harrop JS</searchLink>; Department of Neurosurgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Guest+JD%22">Guest JD</searchLink>; Department of Neurological Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Schmitt+KM%22">Schmitt KM</searchLink>; Department of Neurosurgery, Health Science Center, University of Texas, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Aarabi+B%22">Aarabi B</searchLink>; Department of Neurosurgery, University of Maryland, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Fehlings+MG%22">Fehlings MG</searchLink>; Division of Neurosurgery and Spine Program, Toronto Western Hospital, University of Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Boakye+M%22">Boakye M</searchLink>; Department of Neurosurgery, University of Louisville, Louisville, Kentucky, USA.<br /><searchLink fieldCode="AU" term="%22Grossman+RG%22">Grossman RG</searchLink>; Department of Neurosurgery, Houston Methodist Research Institute, Houston, Texas, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228811626%22">Journal of neurotrauma</searchLink> [J Neurotrauma] 2023 Sep; Vol. 40 (17-18), pp. 1889-1906. – Name: TypePub Label: Publication Type Group: TypPub Data: Randomized Controlled Trial; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Mary+Ann+Liebert%22">Mary Ann Liebert </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8811626 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-9042 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208977151%22">08977151 </searchLink><i>NLM ISO Abbreviation: </i>J Neurotrauma <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37130044 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1089/neu.2022.0499 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1889 Titles: – TitleFull: Riluzole in Spinal Cord Injury Study (RISCIS)-Pharmacokinetic (PK) Sub-Study: An Analysis of Pharmacokinetics, Pharmacodynamics, and Impact on Axonal Degradation of Riluzole in Patients With Traumatic Cervical Spinal Cord Injury Enrolled in the RISCIS Phase III Randomized Controlled Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chow DS – PersonEntity: Name: NameFull: Nguyen A – PersonEntity: Name: NameFull: Park J – PersonEntity: Name: NameFull: Wu L – PersonEntity: Name: NameFull: Toups EG – PersonEntity: Name: NameFull: Harrop JS – PersonEntity: Name: NameFull: Guest JD – PersonEntity: Name: NameFull: Schmitt KM – PersonEntity: Name: NameFull: Aarabi B – PersonEntity: Name: NameFull: Fehlings MG – PersonEntity: Name: NameFull: Boakye M – PersonEntity: Name: NameFull: Grossman RG IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2023 Sep Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1557-9042 Numbering: – Type: volume Value: 40 – Type: issue Value: 17-18 Titles: – TitleFull: Journal of neurotrauma Type: main |
| ResultId | 1 |
